...AstraZeneca has AZD1390 in Phase I testing for brain cancer. Merck KGaA has M-3541 and Shuttle Pharmaceuticals Inc....

...Ltd. (TPEx-E:6453) 3/3/17 TBD Ph III Iaso BioMed Inc. (OTCQB) 12/14/16 Up to $5M Preclin Shuttle Pharmaceuticals Inc....

...TPEx-E:6453) (D) 3/3/17 TBD Ph III Iaso BioMed Inc. (OTCQB) 12/14/16 Up to $5M Preclin Shuttle Pharmaceuticals Inc....

...NASDAQ:BIIB); GV; Hatteras Venture Partners; Johnson & Johnson Development Corp.; Remeditex Ventures; Third Point Ventures Shuttle Pharmaceuticals Inc....

...TPEx-E:6453) (D) 3/3/17 TBD Ph III Iaso BioMed Inc. (OTCQB) 12/14/16 Up to $5M Preclin Shuttle Pharmaceuticals Inc....

...1/4/17 TBD Mkt (tools & services) Iaso Biomed Inc. (OTCQB) 12/14/16 Up to $5M Preclin Shuttle Pharmaceuticals Inc....

...12/30/16 Up to $86.3M Ph II Iaso Biomed Inc. (OTCQB) 12/14/16 Up to $5M Preclin Shuttle Pharmaceuticals Inc....

...at $8 in a self-underwritten, best efforts IPO on NYSE MKT. Shuttle Pharmaceuticals Inc. , Rockville, Md. Alicia Parker Shuttle Pharmaceuticals Inc....